Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    Open Studies | Exclude Unknown | liver disease | NIDDK
Show Display Options
Rank Status Study
1 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
2 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
3 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
4 Recruiting Longitudinal Study of Mitochondrial Hepatopathies
Conditions: Acute Liver Failure,;   Mitochondrial Diseases;   End Stage Liver Disease,;   Respiratory Chain Deficiencies, Mitochondrial;   Disorder of Fatty Acid Oxidation
5 Not yet recruiting FibroScan™ in Pediatric Cholestatic Liver Disease Study Protocol
Conditions: Biliary Atresia;   Alagille Syndrome;   Alpha1 Anti-Trypsin Deficiency;   Portal Hypertension;   Liver Fibrosis;   Cholestasis
Intervention: Other: Liver Stiffness Measurement (LSM)
6 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
7 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
8 Recruiting Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
Condition: Fatty Liver
9 Recruiting Evaluation of Sickle Cell Liver Disease
Condition: Sickle Cell Disease
10 Recruiting Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
Conditions: Healthy;   NAFLD (Non-Alcoholic Fatty Liver Disease);   NASH (Non-Alcoholic Steatohepatitis)
Interventions: Other: NAFLD/NASH - Placebo;   Dietary Supplement: NAFLD/NASH - Vitamin E
11 Recruiting DILIN's Prospective Study
Condition: Liver Diseases
12 Recruiting Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Conditions: Alpha-1-antitrypsin Deficiency;   Liver Cirrhosis
Interventions: Drug: Drug-Carbamazepine (Tegretol XR);   Drug: Carbamazepine (Tegretol XR) Placebo
13 Recruiting Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
Conditions: Liver Diseases;   Portal Hypertension
Intervention: Drug: SHAPE measurement (Sonazoid ultrasoud contrast agent)
14 Recruiting Mitochondrial Function in Patients With Severe Liver Disease
Conditions: Hepatic Insufficiency;   Hypoalbuminemia
Intervention: Other: Orally administered labeled glycerol
15 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;   Drug: Vitamin E 400 IU/d;   Drug: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
16 Recruiting Biliary Atresia Research Consortium
Conditions: Biliary Atresia;   Cholestasis
17 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
18 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
19 Recruiting A Multi-Center Trial to Study Acute Liver Failure in Adults
Conditions: Acute Liver Failure;   Fulminant Hepatic Failure;   Acute Liver Injury
20 Recruiting Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Condition: Cirrhosis

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years